Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Evotec AG Stock

Price
 
€18.56
-0.07
-0.380%
Target price
€25.00
11:49 / Tradegate WKN: 566480 / Name: Evotec / Stock / Biotechnologie & medizinische Forschung
Latest predictions
-
18.11.19
buy
-
14.11.19
buy
€28.00
12.11.19
buy
€25.00
09.11.19
buy
-
08.11.19
-
05.11.19
Your prediction

Evotec AG Stock

The price for the Evotec AG stock decreased slightly today. Compared to yesterday there is a change of -€0.070 (-0.380%).
With 27 Buy predictions and 4 Sell predictions Evotec AG is one of the favorites of our community.
With a target price of €25.00 there is a positive potential of 34.698% for Evotec AG compared to the current price of €18.56.
Register To Post

Other discussions about Evotec AG Stock

Trading Evotec AG

Trading Evotec AG

New thread

News

DGAP-News: EVOTEC REACHES MILESTONE IN INTEGRATED DRUG DISCOVERY AND DEVELOPMENT PARTNERSHIP WITH AEOVIAN: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC REACHES MILESTONE IN INTEGRATED DRUG DISCOVERY AND DEVELOPMENT PARTNERSHIP WITH AEOVIAN

DGAP-News: EVOTEC REACHES MILESTONE IN INTEGRATED DRUG DISCOVERY AND DEVELOPMENT PARTNERSHIP WITH AEOVIAN

DGAP-News: EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES

DGAP-News: EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES

DGAP-News: EVOTEC SE REPORTS FIRST NINE-MONTH 2019 RESULTS AND CORPORATE UPDATES: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC SE REPORTS FIRST NINE-MONTH 2019 RESULTS AND CORPORATE UPDATES

DGAP-News: EVOTEC SE REPORTS FIRST NINE-MONTH 2019 RESULTS AND CORPORATE UPDATES

DGAP-News: EVOTEC AND VIFOR PHARMA FORM JOINT VENTURE FOR EARLY DEVELOPMENT IN NEPHROLOGY: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND VIFOR PHARMA FORM JOINT VENTURE FOR EARLY DEVELOPMENT IN NEPHROLOGY

DGAP-News: EVOTEC AND VIFOR PHARMA FORM JOINT VENTURE FOR EARLY DEVELOPMENT IN NEPHROLOGY

DGAP-News: EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2019  ON 12 NOVEMBER 2019: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2019 ON 12 NOVEMBER 2019

DGAP-News: EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2019 ON 12 NOVEMBER 2019

DGAP-News: EVOTEC, INTEGRA HOLDINGS AND YISSUM ESTABLISH LAB555 TO FAST TRACK EARLY-STAGE DRUG DEVELOPMENT: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC, INTEGRA HOLDINGS AND YISSUM ESTABLISH LAB555 TO FAST TRACK EARLY-STAGE DRUG DEVELOPMENT

DGAP-News: EVOTEC, INTEGRA HOLDINGS AND YISSUM ESTABLISH LAB555 TO FAST TRACK EARLY-STAGE DRUG DEVELOPMENT

DGAP-News: JUST - EVOTEC BIOLOGICS & BIOCON BIOLOGICS SIGN LICENSING DEAL FOR A BIOSIMILAR ASSET: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: JUST - EVOTEC BIOLOGICS & BIOCON BIOLOGICS SIGN LICENSING DEAL FOR A BIOSIMILAR ASSET

DGAP-News: JUST - EVOTEC BIOLOGICS & BIOCON BIOLOGICS SIGN LICENSING DEAL FOR A BIOSIMILAR ASSET

DGAP-News: EVOTEC AND CELMATIX ENTER INTO STRATEGIC COLLABORATION: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND CELMATIX ENTER INTO STRATEGIC COLLABORATION

DGAP-News: EVOTEC AND CELMATIX ENTER INTO STRATEGIC COLLABORATION